A Study on Adverse Drug Reactions to first line Antitubercular Drugs in DOTS Therapy

International Journal of Pharmacology and Clinical Sciences, 2015, 4, 1, 7-11.Published: March 2015Type: Research ArticleAuthors: Athira B, Manju CS, Jyothi E Author(s) affiliations: Athira B1*, Manju CS2, Jyothi E3 1M.Pharm student, 2Assistant Professor, College of pharmaceutical sciences, Government Medical College, Kozhikode, Kerala, India. 3Assistant Professor, Institute of Chest Disease, Government Medical College, Kozhikode, Kerala, India. […]

Saroglitazar: India’s Answer to Diabetic Dyslipidemia

International Journal of Pharmacology and Clinical Sciences, 2014, 3, 1, 7-14.Published: March 2014Type: New drug informationAuthors: Akanksha Aggarwal Author(s) affiliations:Akanksha Aggarwal Post Graduate, Department of Pharmaceutics, Delhi Institute of Pharmaceutical Sciences and Research, New Delhi, India Abstract Incidence of dyslipidemia among people suffering from diabetes is shooting up each year around the globe. A novel […]

Comparative Evaluation of Antimicrobial and Anticonvulsant Induced Cases of Steven Johnson Syndrome and Toxic Epidermal Necrolysis

International Journal of Pharmacology and Clinical Sciences, 2014, 3, 1, 1-6.Published: March 2014Type: Research ArticleAuthors: Surabhi Dayal, Brahmita Monga, V. K. Jain, Kamal Aggarwal, and Anuradha Author(s) affiliations:Surabhi Dayal1, Brahmita Monga2*, V. K. Jain3, Kamal Aggarwal1, Anuradha4 1Professor, 2Post Graduate, 3Senior Professor and Head, Department of Dermatology, venereology and leprology,4Senior Resident, Department of Preventive and […]